Related Experiment Video
Updated: Apr 30, 2026

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
Observational Study on the Effectiveness of L-Arginine Plus Vitamin C in the Management of Cancer-related Fatigue
Vittorio Gebbia1, Giuseppa Scandurra2,3, Daniela Sambataro2,4
1Medical Oncology Chair, Kore University of Enna, Enna, Italy; vittorio.gebbia@unikore.it.
Background/Aim:
Cancer-related fatigue is one of the most distressing symptoms reported by patients with neoplastic disease. L-Arginine has a positive effect on physical performance in healthy individuals, on fatigue in diseases other than cancer, and on immune response in patients with cancer.
Patients And Methods:
Forty-four patients with cancer undergoing medical treatment were treated orally with 1.66 g L-arginine and 500 mg of vitamin C b.i.d. Cancer-related fatigue and health-related quality of life were recorded before treatment and after 15 and 30 days of supplementation employing a visual analog scale and the European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30) respectively.
Results:
Daily oral supplementation with L-arginine and vitamin C ameliorated cancer-related fatigue in a statistically significant manner. Health-related quality of life remained mostly unchanged despite patients having advanced cancer and being administered medical treatments including chemotherapy, immunotherapy and biological agents. No effect on appetite preservation was observed, except in a small percentage of patients.
Conclusion:
Our exploratory study suggests a positive effect of oral supplementation with L-arginine plus vitamin C on cancer-related fatigue without significant worsening of quality of life. Due to the heterogeneity of the patient sample, further studies are needed including more clinically homogenous groups of patients.
Related Concept Videos
Cancer Prevention
Some...
Angina V: Nursing Management
Cancer Survival Analysis
COPD: Management Using Bronchodilators and Corticosteroids
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Heart Failure VI: Adjunct Therapies

